Literature DB >> 22833756

Nocebo phenomena in medicine: their relevance in everyday clinical practice.

Winfried Häuser1, Ernil Hansen, Paul Enck.   

Abstract

BACKGROUND: Nocebo phenomena are common in clinical practice and have recently become a popular topic of research and discussion among basic scientists, clinicians, and ethicists.
METHODS: We selectively searched the PubMed database for articles published up to December 2011 that contained the key words "nocebo" or "nocebo effect."
RESULTS: By definition, a nocebo effect is the induction of a symptom perceived as negative by sham treatment and/or by the suggestion of negative expectations. A nocebo response is a negative symptom induced by the patient's own negative expectations and/or by negative suggestions from clinical staff in the absence of any treatment. The underlying mechanisms include learning by Pavlovian conditioning and reaction to expectations induced by verbal information or suggestion. Nocebo responses may come about through unintentional negative suggestion on the part of physicians and nurses. Information about possible complications and negative expectations on the patient's part increases the likelihood of adverse effects. Adverse events under treatment with medications sometimes come about by a nocebo effect.
CONCLUSION: Physicians face an ethical dilemma, as they are required not just to inform patients of the potential complications of treatment, but also to minimize the likelihood of these complications, i.e., to avoid inducing them through the potential nocebo effect of thorough patient information. Possible ways out of the dilemma include emphasizing the fact that the proposed treatment is usually well tolerated, or else getting the patient's permission to inform less than fully about its possible side effects. Communication training in medical school, residency training, and continuing medical education would be desirable so that physicians can better exploit the power of words to patients' benefit, rather than their detriment.

Entities:  

Mesh:

Year:  2012        PMID: 22833756      PMCID: PMC3401955          DOI: 10.3238/arztebl.2012.0459

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  46 in total

1.  Importance of recognizing that surgical patients behave as though hypnotized.

Authors:  D B CHEEK
Journal:  Am J Clin Hypn       Date:  1962-04

2.  The powerful placebo.

Authors:  H K BEECHER
Journal:  J Am Med Assoc       Date:  1955-12-24

3.  The role of placebo and nocebo effects of perioperative administration of sedatives and opioids in interventional pain management.

Authors:  Laxmaiah Manchikanti; Vidyasagar Pampati; Kim Damron
Journal:  Pain Physician       Date:  2005-10       Impact factor: 4.965

4.  Expectation and the placebo effect in Parkinson's disease patients with subthalamic nucleus deep brain stimulation.

Authors:  Rodrigo Mercado; Constantine Constantoyannis; Tomasz Mandat; Ajit Kumar; Michael Schulzer; A Jon Stoessl; Christopher R Honey
Journal:  Mov Disord       Date:  2006-09       Impact factor: 10.338

5.  The effect of using standardized patients or peer role play on ratings of undergraduate communication training: a randomized controlled trial.

Authors:  Hans Martin Bosse; Jobst-Hendrik Schultz; Martin Nickel; Thomas Lutz; Andreas Möltner; Jana Jünger; Sören Huwendiek; Christoph Nikendei
Journal:  Patient Educ Couns       Date:  2011-12-01

6.  The biochemical and neuroendocrine bases of the hyperalgesic nocebo effect.

Authors:  Fabrizio Benedetti; Martina Amanzio; Sergio Vighetti; Giovanni Asteggiano
Journal:  J Neurosci       Date:  2006-11-15       Impact factor: 6.167

7.  Fear-avoidance behavior and anticipation of pain in patients with chronic low back pain: a randomized controlled study.

Authors:  M Pfingsten; E Leibing; W Harter; B Kröner-Herwig; D Hempel; U Kronshage; J Hildebrandt
Journal:  Pain Med       Date:  2001-12       Impact factor: 3.750

8.  Nocebo as headache trigger: evidence from a sham-controlled provocation study with RF fields.

Authors:  L J Stovner; G Oftedal; A Straume; A Johnsson
Journal:  Acta Neurol Scand Suppl       Date:  2008

Review 9.  Adverse events attributable to nocebo in randomized controlled drug trials in fibromyalgia syndrome and painful diabetic peripheral neuropathy: systematic review.

Authors:  Winfried Häuser; Claas Bartram; Eva Bartram-Wunn; Thomas Tölle
Journal:  Clin J Pain       Date:  2012-06       Impact factor: 3.442

10.  Evaluation of the nocebo effect during oral challenge in patients with adverse drug reactions.

Authors:  G Liccardi; G Senna; M Russo; P Bonadonna; M Crivellaro; A Dama; M D'Amato; G D'Amato; G W Canonica; G Passalacqua
Journal:  J Investig Allergol Clin Immunol       Date:  2004       Impact factor: 4.333

View more
  73 in total

1.  Adverse events during placebo vs. no drug administration--results of a randomised interventional trial in 160 volunteers.

Authors:  Frank Erbguth; Angelika Hamacher-Erbguth; Uwe Fuhr; Fritz Sörgel
Journal:  Eur J Clin Pharmacol       Date:  2015-08-14       Impact factor: 2.953

Review 2.  [Placebo and nocebo : How can they be used or avoided?]

Authors:  E Hansen; N Zech; K Meissner
Journal:  Internist (Berl)       Date:  2017-10       Impact factor: 0.743

3.  [Treatment of pain in people with dementia].

Authors:  Matthias Schuler
Journal:  Z Gerontol Geriatr       Date:  2019-07-25       Impact factor: 1.281

4.  Memory and Hashimoto's thyroiditis under levothyroxine treatment: is there a placebo or nocebo effect?

Authors:  Vaitsa Giannouli
Journal:  Endocrine       Date:  2017-02-16       Impact factor: 3.633

5.  In reply.

Authors:  Ernil Hansen
Journal:  Dtsch Arztebl Int       Date:  2013-01-25       Impact factor: 5.594

6.  Unintended answer to the nocebo question.

Authors:  Reinhard Bauß
Journal:  Dtsch Arztebl Int       Date:  2013-01-25       Impact factor: 5.594

7.  A placebo-controlled, blinded and randomised study on the effects of recombinant human thyrotropin on quality of life in the treatment of thyroid cancer.

Authors:  Birte Nygaard; Lars Bastholt; Finn Noe Bennedbæk; Tobias Wirenfeldt Klausen; Jens Bentzen
Journal:  Eur Thyroid J       Date:  2013-09-07

8.  Harnessing the placebo effect in pediatric migraine clinic.

Authors:  Vanda Faria; Clas Linnman; Alyssa Lebel; David Borsook
Journal:  J Pediatr       Date:  2014-07-22       Impact factor: 4.406

9.  Placebo and Active Treatment Additivity in Placebo Analgesia: Research to Date and Future Directions.

Authors:  Matthew J Coleshill; Louise Sharpe; Luana Colloca; Robert Zachariae; Ben Colagiuri
Journal:  Int Rev Neurobiol       Date:  2018-08-06       Impact factor: 3.230

Review 10.  Chronic tinnitus: an interdisciplinary challenge.

Authors:  Peter M Kreuzer; Veronika Vielsmeier; Berthold Langguth
Journal:  Dtsch Arztebl Int       Date:  2013-04-19       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.